These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 23053273)
1. Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response. Litviakov NV; Cherdyntseva NV; Tsyganov MM; Denisov EV; Garbukov EY; Merzliakova MK; Volkomorov VV; Vtorushin SV; Zavyalova MV; Slonimskaya EM; Perelmuter VM Cancer Chemother Pharmacol; 2013 Jan; 71(1):153-63. PubMed ID: 23053273 [TBL] [Abstract][Full Text] [Related]
2. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy]. Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034 [TBL] [Abstract][Full Text] [Related]
3. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy. Litviakov NV; Cherdyntseva NV; Tsyganov MM; Slonimskaya EM; Ibragimova MK; Kazantseva PV; Kzhyshkowska J; Choinzonov EL Oncotarget; 2016 Feb; 7(7):7829-41. PubMed ID: 26799285 [TBL] [Abstract][Full Text] [Related]
4. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients. Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900 [TBL] [Abstract][Full Text] [Related]
5. Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer. Tsyganov MM; Freidin MB; Ibragimova MK; Deryusheva IV; Kazantseva PV; Slonimskaya EM; Cherdyntseva NV; Litviakov NV Cancer Chemother Pharmacol; 2017 Aug; 80(2):251-260. PubMed ID: 28601971 [TBL] [Abstract][Full Text] [Related]
6. Basal-like molecular subtype and HER4 up-regulation and response to neoadjuvant chemotherapy in breast cancer. Stickeler E; Pils D; Klar M; Orlowsk-Volk M; Zur Hausen A; Jäger M; Watermann D; Gitsch G; Zeillinger R; Tempfer CB Oncol Rep; 2011 Oct; 26(4):1037-45. PubMed ID: 21769435 [TBL] [Abstract][Full Text] [Related]
7. PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy. Chen YZ; Xue JY; Chen CM; Yang BL; Xu QH; Wu F; Liu F; Ye X; Meng X; Liu GY; Shen ZZ; Shao ZM; Wu J Cancer Chemother Pharmacol; 2012 Nov; 70(5):637-44. PubMed ID: 22903535 [TBL] [Abstract][Full Text] [Related]
8. Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease. Modlich O; Prisack HB; Munnes M; Audretsch W; Bojar H Clin Cancer Res; 2004 Oct; 10(19):6418-31. PubMed ID: 15475428 [TBL] [Abstract][Full Text] [Related]
10. HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer. Andre F; Mazouni C; Liedtke C; Kau SW; Frye D; Green M; Gonzalez-Angulo AM; Symmans WF; Hortobagyi GN; Pusztai L Breast Cancer Res Treat; 2008 Mar; 108(2):183-90. PubMed ID: 17468948 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of expression of multidrug resistance gene in breast cancer tissue]. Liu X; Song S; Shi C Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):488-90. PubMed ID: 9772445 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures. Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249 [TBL] [Abstract][Full Text] [Related]
13. MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy? McGuire KP; Toro-Burguete J; Dang H; Young J; Soran A; Zuley M; Bhargava R; Bonaventura M; Johnson R; Ahrendt G Ann Surg Oncol; 2011 Oct; 18(11):3149-54. PubMed ID: 21947592 [TBL] [Abstract][Full Text] [Related]
14. DNA repair signature is associated with anthracycline response in triple negative breast cancer patients. Rodriguez AA; Makris A; Wu MF; Rimawi M; Froehlich A; Dave B; Hilsenbeck SG; Chamness GC; Lewis MT; Dobrolecki LE; Jain D; Sahoo S; Osborne CK; Chang JC Breast Cancer Res Treat; 2010 Aug; 123(1):189-96. PubMed ID: 20582464 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics. Lips EH; Mulder L; de Ronde JJ; Mandjes IA; Vincent A; Vrancken Peeters MT; Nederlof PM; Wesseling J; Rodenhuis S Breast Cancer Res Treat; 2012 Feb; 131(3):827-36. PubMed ID: 21472434 [TBL] [Abstract][Full Text] [Related]
16. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294 [TBL] [Abstract][Full Text] [Related]
17. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer. Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665 [TBL] [Abstract][Full Text] [Related]
18. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer. Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer. Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949 [TBL] [Abstract][Full Text] [Related]
20. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP. Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]